4.3 Article

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

Satish K. Garg et al.

Summary: The PROMISE study evaluated the accuracy and safety of the next-generation implantable Eversense CGM system for up to 180 days. The results showed sustained accuracy and safety of the system, with improved calibration scheme and sensor survival, using either primary or SBA sensors.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Article Endocrinology & Metabolism

Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes

Tatsuhiko Urakami et al.

Summary: This study examined the impact of scanning frequency with flash glucose monitoring on glycemic control in children and adolescents with type 1 diabetes. The results showed that higher scanning frequency was associated with better glycemic control, with greater TIRs and lower HbA1c levels. Patients scanning more than 12 times/day had significantly better glycemic outcomes compared to those scanning less frequently.

JOURNAL OF DIABETES INVESTIGATION (2022)

Article Endocrinology & Metabolism

Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes

Shridhara Alva et al.

Summary: This study evaluated the analytical performance of the second-generation factory-calibrated FreeStyle Libre 2 system compared to the YSI reference. The results showed that the system performed well in terms of accuracy and bias during the 14-day sensor wear period. It demonstrated excellent performance in the hypoglycemic range.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)

Article Pediatrics

Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes

Junichi Suzuki et al.

Summary: Through assessing the scanning frequency of FGM in 85 children and adolescents with type 1 diabetes, it was found that the scanning frequency was significantly positively correlated with time in range and inversely correlated with time above range, but not correlated with time below range. Additionally, scanning frequency showed significant inverse correlations with glucose, HbA1c, and eA1c levels.

PEDIATRICS INTERNATIONAL (2021)

Article Endocrinology & Metabolism

Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes

Torben Biester et al.

Summary: Real-world analysis showed that intermittent scanning continuous glucose monitoring can improve glycemic control in children and adolescents with type 1 diabetes, with the intensity of device use having a direct impact on control.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Review Psychology, Developmental

Systematic Review: Diabetes Family Conflict in Young People With Type 1 Diabetes

Anna Hickling et al.

Summary: Diabetes-specific family conflict is significantly associated with adverse health outcomes in young people with T1D, including higher HbA1c values and decreased treatment adherence. In young people with T1D, family conflict can lead to poorer quality of life and negative psychological symptoms. Additional longitudinal studies focusing on young people older than 16 years are needed to further explore these relationships and implications.

JOURNAL OF PEDIATRIC PSYCHOLOGY (2021)

Article Endocrinology & Metabolism

Inaccurate Glucose Sensor Values After Hydroxyurea Administration

Siobhan E. Tellez et al.

Summary: The study evaluated the impact of hydroxyurea (HU) administration on continuous glucose monitoring (CGM) systems in patients, finding a significant rise in sensor readings from 0.5-6 hours after administration. It is recommended that patients rely on glucometer testing during this period.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes

Nancy Elbarbary et al.

Summary: Early control of blood glucose is crucial in reducing vascular complications in individuals with Type 1 diabetes. Encouraging children and adolescents with T1DM to take charge of controlling glucose levels is important but challenging. The use of continuous glucose monitoring systems allows for comprehensive analysis of blood glucose levels in T1D patients and can help them take actions to maintain glucose levels near physiological levels.

DIABETES & VASCULAR DISEASE RESEARCH (2021)

Article Endocrinology & Metabolism

Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID-19 global pandemic

Angelica Cristello Sarteau et al.

Summary: The study explored provider perceptions of care adaptations and challenges in response to COVID-19 across nine international pediatric diabetes clinics. Providers expressed concerns about potential negative impacts on patients from COVID-19 and clinical adaptations, while also acknowledging the opportunities for improving care and self-management recommendations in the future.

PEDIATRIC DIABETES (2021)

Article Endocrinology & Metabolism

Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic

Joyce M. Lee et al.

Summary: During the COVID-19 pandemic, there was rapid adoption of telemedicine in the T1D Exchange Quality Improvement Collaborative (T1DX-QI), with a significant increase in telemedicine visits proportion that later slightly decreased. Most clinics utilized both video and telephone visits, with Zoom being the most popular video platform.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

A decade of improved glycemic control in young children with type 1 diabetes: A population-based cohort study

Frida Sundberg et al.

Summary: Over the past decade, the usage of CGM and insulin pump increased while HbA1c levels decreased in children under 7 with T1D in Sweden. However, HbA1c levels remained higher than physiological levels and continued to pose cardiovascular risks, especially in conjunction with overweight or obesity. The frequency of overweight and obesity remained unchanged.

PEDIATRIC DIABETES (2021)

Article Endocrinology & Metabolism

Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives

Irl B. Hirsch et al.

Summary: Numerous studies have shown the benefits of continuous glucose monitoring (CGM) for individuals with diabetes. While demand for CGM in primary care is increasing, many clinicians are hesitant to prescribe it due to lack of familiarity with different devices and uncertainty about which device is best for each patient. This article reviews recent commercially available CGM devices and provides guidance on integrating CGM into clinical practices.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

Diabetes distress and glycaemic control in young adults with type 1 diabetes: Associations by use of insulin pumps and continuous glucose monitors

Kathryn E. Nagel et al.

Summary: The study found that high diabetes distress in young adults is associated with higher HbA(1c) levels, regardless of whether they are using diabetes devices. This suggests that young adults with high diabetes distress may need more attention in managing their diabetes, even if they are using insulin pumps and CGMs.

DIABETIC MEDICINE (2021)

Article Endocrinology & Metabolism

Predictors of mood, diabetes-specific and COVID-19-specific experiences among parents of early school-age children with type 1 diabetes during initial months of the COVID-19 pandemic

Christine H. Wang et al.

Summary: This study found that higher pre-pandemic social support predicted fewer depressive symptoms, more positive diabetes-specific experiences, and less COVID-19-specific distress during the pandemic. Heavier pre-pandemic depressive symptoms predicted more depressive symptoms during the pandemic. More life disruptions due to the pandemic were associated with more negative diabetes-specific experiences and more COVID-19-specific distress.

PEDIATRIC DIABETES (2021)

Article Chemistry, Analytical

Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study

Yannis Preau et al.

Summary: The study found that switching from FSL1 to DG4 for glucose monitoring can effectively improve glycemic management in type 1 diabetes patients, showing long-term effectiveness in improving blood sugar control. Despite significant improvements in hypoglycemia, optimization is still needed for controlling hyperglycemia.

SENSORS (2021)

Article Allergy

Contact dermatitis caused by glucose sensors in diabetic children

Anne Herman et al.

CONTACT DERMATITIS (2020)

Article Endocrinology & Metabolism

Use of Diabetes Technology in Children Role of Structured Education for Young People with Diabetes and Families

Hannah R. Desrochers et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)

Article Medicine, General & Internal

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes A Randomized Clinical Trial

Lori M. Laffel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Endocrinology & Metabolism

Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies

Nurul A. Mohd Asarani et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring in Children with Type 1 Diabetes Improves Well-Being, Alleviates Worry and Fear of Hypoglycemia

Sze May Ng et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

Mark P. Christiansen et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes

Marisa E. Hilliard et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus

Susana R. Patton et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Continuous glucose monitoring use and glucose variability in pre-school children with type 1 diabetes

Klemen Dovc et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2019)

Article Endocrinology & Metabolism

Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes

Giacomo Mulinacci et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 Diabetes

Marie-Anne Burckhardt et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018

Nicole C. Foster et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes

Michelle A. Van Name et al.

PEDIATRIC DIABETES (2018)

Article Endocrinology & Metabolism

Preserving Skin Integrity with Chronic Device Use in Diabetes

Laurel H. Messer et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator

Viral N. Shah et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes

Peter Adolfsson et al.

PEDIATRIC DIABETES (2018)

Review Endocrinology & Metabolism

A Review of Blood Glucose Monitor Accuracy

Fraya King et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study)

Maria del Rosario Vallejo Mora et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2017)

Article Endocrinology & Metabolism

Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology

Udo Hoss et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2017)

Article Endocrinology & Metabolism

Barriers to Active Lifestyles in Children with Type 1 Diabetes

Georges Jabbour et al.

CANADIAN JOURNAL OF DIABETES (2016)

Article Endocrinology & Metabolism

Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study

Ananda Basu et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2016)

Article Endocrinology & Metabolism

Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring

Ahmed H. El-Laboudi et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2016)

Letter Endocrinology & Metabolism

Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery

Martin I. de Bock et al.

DIABETES CARE (2015)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring in 2014

Bruce W. Bode et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2015)

Article Endocrinology & Metabolism

Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring

Boris P. Kovatchev et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2015)

Article Endocrinology & Metabolism

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Timothy Bailey et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2015)

Article Endocrinology & Metabolism

Remote Glucose Monitoring in Camp Setting Reduces the Risk of Prolonged Nocturnal Hypoglycemia

Daniel J. DeSalvo et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2014)

Article Endocrinology & Metabolism

Psychosocial Correlates of Continuous Glucose Monitoring Use in Youth and Adults with Type 1 Diabetes and Parents of Youth

Jessica T. Markowitz et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2012)

Review Medicine, General & Internal

Continuous glucose monitoring systems for type 1 diabetes mellitus

Miranda W. Langendam et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)

Article Medicine, General & Internal

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Richard M. Bergenstal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Pediatrics

Predictors of control of diabetes: Monitoring may be the key

MJ Haller et al.

JOURNAL OF PEDIATRICS (2004)